Drug Halves Tumor Recurrence for Women With a Common Breast Cancer
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Too Much Time in the Sun? Skin Patch Might Tell
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Drug Halves Tumor Recurrence for Women With a Common Breast Cancer
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Demystifying immunity in the bladder
The EU-funded UPECBCG project set out to study the bladder's immune system, with the aim of advancing our understanding of UTI and bladder cancer to improve treatment of these diseases. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - December 5, 2018 Category: Research Source Type: news

Armstrong Ambulance Drops Santa Off at Saugus Fundraiser
ARLINGTON, Mass. — Armstrong Ambulance is pleased to announce that one of its ambulances recently dropped off Santa Claus to a fundraiser in Saugus to raise money for the Relay for Life. On Saturday, Dec. 1, Armstrong Ambulance dropped Old Saint Nick off at Fuddruckers in Saugus to help raise money for the Relay For Life cancer walk. Relay For Life is a fundraising event for the American Cancer Society that organizes community walks to raise money for cancer research. "We were glad to be able to give Santa a ride to this great fundraising event," Armstrong CEO Richard Raymond said. "While our ambulance...
Source: JEMS: Journal of Emergency Medical Services News - December 4, 2018 Category: Emergency Medicine Authors: Armstrong Ambulance Service (press release) Tags: Administration and Leadership Industry News Press Releases Source Type: news

Armstrong Ambulance Drops Santa Off at Saugus Fundraiser
ARLINGTON, Mass. — Armstrong Ambulance is pleased to announce that one of its ambulances recently dropped off Santa Claus to a fundraiser in Saugus to raise money for the Relay for Life. On Saturday, Dec. 1, Armstrong Ambulance dropped Old Saint Nick off at Fuddruckers in Saugus to help raise money for the Relay For Life cancer walk. Relay For Life is a fundraising event for the American Cancer Society that organizes community walks to raise money for cancer research. "We were glad to be able to give Santa a ride to this great fundraising event," Armstrong CEO Richard Raymond said. "While our ambulance...
Source: JEMS Administration and Leadership - December 4, 2018 Category: Emergency Medicine Authors: Armstrong Ambulance Service (press release) Tags: Administration and Leadership Industry News Press Releases Source Type: news

The First Baby Has Been Born After a Uterus Transplant From a Deceased Donor
The world’s first baby born by a uterus transplant from a deceased donor is healthy and nearing her first birthday, according to a new case study published Tuesday in the Lancet. Uterus transplants have become more common in recent years, resulting in 11 live births around the world. But all of the other successful deliveries so far have been made possible by living donors — often women who opt to donate their uterus to a close friend or family member without one. The birth resulting from the case detailed in the Lancet, which took place at Brazil’s Hospital das Clínicas last December, is both the first...
Source: TIME: Health - December 4, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized fertility healthytime Source Type: news

UAB Comprehensive Cancer Center gets $30M gift from O'Neal Industries
O'Neal Industries and its shareholders have given the UAB Comprehensive Cancer Center the largest gift in UAB history. The $30 million gift will allow the cancer center to recruit additional cancer scientists and clinicians, expand cancer treatment clinical trials at UAB, plant the seed for a UAB/biotech collaboration that could eventually grow into a Birmingham biotechnology park and create a distinctive brand ar ound the cancer center. Moving forward, the center will be known as the O’Neal… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 4, 2018 Category: Biotechnology Authors: Ty West Source Type: news

UAB Comprehensive Cancer Center gets $30M gift from O'Neal Industries
O'Neal Industries and its shareholders have given the UAB Comprehensive Cancer Center the largest gift in UAB history. The $30 million gift will allow the cancer center to recruit additional cancer scientists and clinicians, expand cancer treatment clinical trials at UAB, plant the seed for a UAB/biotech collaboration that could eventually grow into a Birmingham biotechnology park and create a distinctive brand ar ound the cancer center. Moving forward, the center will be known as the O’Neal… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 4, 2018 Category: Pharmaceuticals Authors: Ty West Source Type: news

Do Oral Side Effects Affect Fentanyl Delivery in Head & amp; Neck Cancer Patients?
Erin McMenamin, CRNP, of Penn Medicine, discusses how oral side effects affect head and neck cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - December 4, 2018 Category: Cancer & Oncology Authors: Lori Smith, BSN, MSN, CRNP Source Type: news

Medical News Today: Does HIV increase cancer risk?
HIV can weaken a person ’s immune system, which can increase the risk of certain types of cancer. Such cancers include Kaposi’s sarcoma, non-Hodgkin lymphoma, and cervical, lung, anal, and oral cancer. However, effective treatment can significantly reduce the risk of developing these cancers. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 4, 2018 Category: Consumer Health News Tags: HIV and AIDS Source Type: news

Wrong connective tissue linked to poorer breast cancer prognosis
Researchers in Sweden have pinpointed two types of connective tissue cells associated with the worse breast cancer prognosis', a study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 4, 2018 Category: Consumer Health News Source Type: news

' Marginal Benefit' With Rivaroxaban in Cancer Patients'Marginal Benefit' With Rivaroxaban in Cancer Patients
The oral drug rivaroxaban was used for prophylaxis against primary venous thromboembolism in ambulatory cancer patients treated in the outpatient setting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Opioid Misuse in Cancer Patients: Fearmongering or Real Risk? Opioid Misuse in Cancer Patients: Fearmongering or Real Risk?
As the opioid crisis goes on, cancer patients are increasingly being caught in the crossfire: is this patient population at risk for abuse or misuse of these drugs?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Scientists develop 10-minute universal cancer test
Inexpensive procedure shows whether patient has cancerous cells in the body, but does not reveal where or how serious it isScientists have developed a universal cancer test that can detect traces of the disease in a patient ’s bloodstream.The cheap and simple test uses a colour-changing fluid to reveal the presence of malignant cells anywhere in the body and provides results in less than 10 minutes.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 4, 2018 Category: Science Authors: Ian Sample Science editor Tags: Cancer research Science Health Medical research Society Source Type: news

New Universal Cancer Test Takes Only Ten Minutes. The Secret Ingredient? Gold.
Researchers from the University of Queensland have invented a new super-quick test for cancer containing gold...and it's likely to be cheaper than other similar tests. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 4, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Medical News Today: Researchers find new drug combo to challenge cancer
Researchers have discovered a new drug combination that may be able to boost cancer treatment while also preventing tumors from becoming therapy-resistant. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 4, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

$5.1B deal: GSK buying ovarian cancer drug developer
In a major move to boost its oncology product pipeline, GlaxoSmithKline entered into a definitive agreement Monday to acquire Boston-area biopharmaceutical company Tesaro for $5.1 billion. Tesaro (NASDAQ: TSRO) of Waltham, Mass., markets the ovarian cancer therapy Zejula, which is approved in the United States and Europe. The company is also conducting clinical trials that if successful could lead to an expanded use of the drug, as a monotherapy and in combination with other ovaria n cancer treatments. “The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 4, 2018 Category: Biotechnology Authors: John George Source Type: news

JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial
Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved survival in blood cancer patients, compared with drugs currently used as the standard of care. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Johnson & Johnson's multiple myeloma drug reduces risk of death in late-stage study
Johnson& Johnson's blockbuster blood cancer drug Darzalex significantly reduced the risk of disease progression or death in patients who have not been previously treated for multiple myeloma, late-stage study data showed on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

New Phase 3 CASSINI Data Presented on the Use of XARELTO ® (rivaroxaban) for Venous Thromboembolism (VTE) Prevention in High-Risk Cancer Patients
(Source: Johnson and Johnson)
Source: Johnson and Johnson - December 4, 2018 Category: Pharmaceuticals Source Type: news

‘ Antimicrobial Resistance Knows No Boundaries ’
Community health worker Urmila Kasdekar performs a health check on a new born baby in Berdaball village of western India. In India, for example, where it is thought that as many as 120,000 babies alone die every year from sepsis caused by antimicrobial-resistant infections, doctors say two of the key factors behind rising AMR are pharmacies selling antibiotics without a prescription and poor infection control in overcrowded healthcare facilities. Credit: Stella Paul/IPSBy Ed HoltBRUSSELS, Dec 4 2018 (IPS)European Union officials and global health bodies have called for help for poorer countries as growing resistance to ant...
Source: IPS Inter Press Service - Health - December 4, 2018 Category: International Medicine & Public Health Authors: Ed Holt Tags: Development & Aid Editors' Choice Europe Featured Global Headlines Health Regional Categories TerraViva United Nations Antimicrobial resistance (AMR) European Centre for Disease Prevention and Control (ECDC) Organisation for Economic Source Type: news

Sexual assault and cancer screening among men and women - Alcal á HE, Keim-Malpass J, Mitchell EM.
Emerging research has shown that experiences of sexual violence are associated with cancer screening behaviors. However, to date, little attention has been given to the impact of sexual assault on cancer screening behaviors, particularly among men. To addr... (Source: SafetyLit)
Source: SafetyLit - December 4, 2018 Category: International Medicine & Public Health Tags: Violence and Weapons Issues Source Type: news

Risk of suicide after cancer diagnosis in England - Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A.
IMPORTANCE: A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. OBJECTIVES: To quantify suicide risk in patie... (Source: SafetyLit)
Source: SafetyLit - December 4, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Treating too lightly? Radiation therapists' experiences of workplace violence when providing care to cancer patients and their families - Sperduti A, Hindle D, Shessel A, Pidgeon B, Akmal H, Chaulk G, DiTomasso A, Divanbeigi L, Rosewall T.
INTRODUCTION: Workplace violence (WPV) is defined as any act in which a person is abused, threatened, intimidated, or assaulted during their employment. Despite an absence of published evidence, radiation therapists (RTs) are considered a "low-risk" profes... (Source: SafetyLit)
Source: SafetyLit - December 4, 2018 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news

Survival trends after inferior vena cava and aortic injuries in the United States - Branco BC, Musonza T, Long MA, Chung J, Todd SR, Wall MJ, Mills JL, Gilani R.
OBJECTIVE: Recent studies have demonstrated an increase in trauma mortality relative to mortality from cancer and heart diseases in the United States. Major vascular injuries such as to the inferior vena cava (IVC) and aortic injuries remain responsible fo... (Source: SafetyLit)
Source: SafetyLit - December 4, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Does science have a bullying problem? - Else H.
In August, accusations of bullying roiled the Institute of Cancer Research in London, one of the leading science centres in the United Kingdom. A prominent cancer researcher there, geneticist Nazneen Rahman, resigned from the institute following an inve... (Source: SafetyLit)
Source: SafetyLit - December 4, 2018 Category: International Medicine & Public Health Tags: Commentary Source Type: news

Early Screening Key to Reducing Lung Cancer Deaths
Radiation oncologist Dr. Andrea McKee believes deaths from lung cancer — including those related to asbestos exposure — could be reduced significantly by increased utilization of early CT screening. McKee, chair of radiation oncology at Lahey Hospital and Medical Center in Burlington, Maine, has been a strong proponent of early screening for several years. “We could be saving tens of thousands of lives every year with this,” McKee told The Mesothelioma Center at Asbestos.com. “There is nothing else like it. The life-saving potential is the most important thing that has happened to cancer in my...
Source: Asbestos and Mesothelioma News - December 4, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

South Florida girl in need of rare blood to fight cancer
A worldwide search is on to find donors of a rare blood type to help save a 2-year-old South Florida girl who is battling cancer (Source: ABC News: Health)
Source: ABC News: Health - December 4, 2018 Category: Consumer Health News Tags: Health Source Type: news

Breast cancer warning - how to reveal your ‘hidden’ risk when simply leaning forward
BREAST cancer symptoms usually include a lump or change to the breast tissue or nipples. But you could also be at risk of the deadly disease if you notice this hidden sign when you lean forward, reveals ITV This Morning ’s Dr Chris. (Source: Daily Express - Health)
Source: Daily Express - Health - December 4, 2018 Category: Consumer Health News Source Type: news

Noninvasive Diagnostic Imaging Accurately IDs Bladder Cancer
TUESDAY, Dec. 4, 2018 -- Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces can detect bladder cancer with high diagnostic accuracy, according to research published online Dec. 3 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 4, 2018 Category: Pharmaceuticals Source Type: news

Prostate cancer - does your wee look like this? Warning signs when you use the toilet
PROSTATE cancer symptoms are difficult to spot in its early stages, but can affect the way you use the toilet. You could be at risk of the condition ’s signs if your urine looks like this. (Source: Daily Express - Health)
Source: Daily Express - Health - December 4, 2018 Category: Consumer Health News Source Type: news

Red tape preventing cancer patients from accessing new drugs
Some cancers have had no new drugs licensed since 2000, according to Institute of Cancer Research reportCancer patients are missing out on innovative new drugs, with red tape covering clinical trials and licensing among the factors to blame, according to a report by theUK ’s Institute of Cancer Research.Children ’s cancers have received little in the way of new treatments, a finding the authors put down to drug companies failing to invest in these rare conditions and using regulatory loopholes to avoid conducting the necessary clinical trials.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 4, 2018 Category: Science Authors: Nicola Davis Tags: Cancer research Medical research Science Health Drugs Society NHS Health policy UK news Source Type: news

Amgen antibody shows promise in myeloma trial, gets FDA fast track
Amgen Inc, updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Money ills add to cancer struggle
(University of Technology Sydney) One in five cancer patients could be experiencing financial difficulties because of their care needs, according to new research published in the Journal of Cancer Survivorship. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Can rice and flushing the toilet be slowly poisoning you?
(Society for Risk Analysis) Rice, barbecued meat and drinking water all pose threats to human health as hosts to potent toxins, carcinogens and opportunistic pathogens. In many cases, the rise in concentrations of these harmful substances is a direct result of human activity, such as the use of harmful pesticides in crops and even advances in green technology. Risk assessment can be a useful tool for determining the actual threat to human health with numerous variables between population groups and degrees of uncertainty. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Expanded cord blood shows potential for use in adult bone marrow transplants
(Duke University Medical Center) Umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Institute of Human Virology researchers discover that a bacterial protein promotes cancer
(University of Maryland School of Medicine) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell's ability to respond to and repair DNA damage, a known origin of cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2018 Category: International Medicine & Public Health Source Type: news

SWOG shares trio of studies at San Antonio breast cancer symposium
(SWOG) SWOG Cancer Research Network members will share the results of three studies at the San Antonio Breast Cancer Symposium, an international gathering of breast cancer physicians and researchers that starts today, with an estimated 7,500 attendees expected from more than 90 countries. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2018 Category: International Medicine & Public Health Source Type: news

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories
(University of California - San Diego) In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 4, 2018 Category: Biology Source Type: news

Cleveland Clinic-led study: Rivaroxaban reduced blood clots and related death in cancer patients
(Cleveland Clinic) Cleveland Clinic medical oncologist and researcher, Alok Khorana, M.D., is the primary investigator on a study that concluded rivaroxaban for venous thromboembolism (VTE), a blood clot in the venous system, significantly reduced VTE and VTE-related death for outpatient, at-risk cancer patients while they were taking the oral blood thinner. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

A universal DNA nano-signature for cancer
(University of Queensland) Researchers from the University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) have discovered a unique nano-scaled DNA signature that appears to be common to all cancers. Based on this discovery, the team has developed a novel technology that enables cancer to be quickly and easily detected from any tissue type, e.g. blood or biopsy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Drug dramatically reduces risk of dangerous blood clots in cancer patients
(The Ottawa Hospital) A large clinical trial published in the New England Journal of Medicine provides the first approach for safely preventing blood clots (venous thromboembolism) in people with cancer. Venous thromboembolism is the second leading cause of death in cancer patients and it can also affect quality of life. About half of people newly diagnosed with a solid cancer could be candidates for the strategy, which involves a low dose of a direct oral anticoagulant called apixaban. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

New possible target for treating major common diseases
(Karolinska Institutet) There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients
(Lund University) In certain forms of cancer, connective tissue forms around and within the tumour. One previously unproven theory is that there are several different types of connective tissue cells with different functions, which affect the development of the tumour in different ways. Now, a research team at Lund University in Sweden has identified three different types of connective tissue cells. In studies of breast cancer patients, the team found that two of these are linked to a worse prognosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Realistic exposure study supports the use of zinc oxide nanoparticle sunscreens
(Elsevier) An important new study provides the first direct evidence that intact zinc oxide nanoparticles neither penetrate the human skin barrier nor cause cellular toxicity after repeated application to human volunteers under in-use conditions. This confirms that the known benefits of using ZnO nanoparticles in sunscreens clearly outweigh the perceived risks, reports the Journal of Investigative Dermatology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories
(University of California - San Diego) In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Immunotherapy pioneers reveal updated efficacy data of tisagenlecleucel CAR T-cell therapy
(Children's Hospital of Philadelphia) Physician-scientists from Children's Hospital of Philadelphia presented updated efficacy and safety data on Kymriah (tisagenlecleucel, formerly CTL019) -- the first-ever FDA-approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers, at the 60th American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Oral cancer prognostic signature identified
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Discovery based on analysis of tissue and saliva samples from oral cancer patients shows a correlation between a signature comprising three peptides and the presence of lymph node metastasis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Russian scientists developed a new drug for cancer diagnostics and treatment
(Sechenov University) Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately. The drug affects tumor cells selectively providing better diagnostics and treatment of malignant tumors (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 4, 2018 Category: Biology Source Type: news